Figure 5

Frequency of CD11b + CD33+ cells and CD4 + CD25 + Foxp3+ cells in the PBMCs. a; Analysis for CD11b as well as CD33 expression by flow cytometry. b; The percentage of CD11b + CD33+ cells of patients with CR, PR and SD (n = 11) (solid line) and PD (n = 3) (dashed line) was measured. *p = 0.043. c; Lymphocytes were identified based on their characteristic properties shown in the FSC and SSC. d; A representative gating was set for CD4+ cells from lymphocytes. e; Analysis for CD25 as well as Foxp3 expression in the CD4+ lymphocytes gate. f; The percentage of CD4 + CD25 + Foxp3+ cells of patients with CR, PR and SD (n = 14) (solid line) and PD (n = 4) (dashed line) was measured. * p = 0.0495.